The global colchicine tablet market size is expected to reach USD 2,552.84 Million in 2030 and register a revenue CAGR of 8.4%, according to the latest report by Reports and Data. Some key factors such as increasing incidences of gout across the globe and increasing prevalence of other related diseases such as Familial Mediterranean Fever (FMF) and arthritis are factors driving global market revenue growth. Increase in the number of clinical trials for colchicine tablet has had a positive impact on the discovery of therapeutic alternatives for a variety of conditions, including cardiovascular diseases, COVID-19 symptom treatment, and others.
colchicine tablet is an alkaloid medication that was first licensed by the Food and Drug Administration (FDA) in 1961 and is mostly used to treat gout attacks. Gout is characterized by joint discomfort and inflammation, and it is caused by an excess of uric acid collecting in joints in the form of needle-like crystals. A gout is simply a severe form of inflammatory arthritis.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2374
Some Key Factors Contributing to the Global Pharma Healthcare Market Growth
Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, increasing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.
Some Key Highlights from the Report:
- Based on dosage formulation, the solid segment accounted for largest revenue share in 2021 and is expected to continue to contribute major revenue share over the forecast period. The solid dosage form of colchicine tablet is preferred owing to ease in preparation, more stable than other forms, appropriate for a long-term release and easy handling.
- Based on application, Familial Mediterranean Fever segment is expected to account for substantially large revenue share during the forecast period. colchicine tablet is so successful at preventing FMF and the development of amyloidosis that the accurate diagnosis and treatment are the most critical parts of medical care.
- On the basis of route of administration, the topical segment is expected to register a robust revenue CAGR throughout the forecast period, owing to evaluation parameter that is considered for topical dosage form are stability, penetrability, solvent property, and others.
- Based on age, geriatric segment is expected to account for substantially large revenue share during the forecast period. Geriatrics are more likely to be prone to Gout arthritis resulting in one of the driving factors for the colchicine tablet market among seniors.
- On the basis of sales channel, the online pharmacies segment is expected to register a robust revenue CAGR throughout the forecast period, owing to its rising popularity because of its ease and convenience.
- Based on end-user, hospitals clinics segment is expected to account for a substantially large revenue share during the forecast period. Growth of the hospitals clinics segment is attributed to increasing number of hospitals in emerging Asian economies.
- North America accounted for largest revenue share in global colchicine tablet market during the forecast period owing to increasing occurrences of gout and pain-related disorders, as well as the rising prevalence of gout treatments in the US
- Asia Pacific is expected to register a robust revenue CAGR throughout the forecast period, owing to increasing research and development activities in the region and growing geriatric population, which is expected to boost the incidence of gout.
- In February 2019, ROMEG Therapeutics announced that the U.S. Food and Drug Administration (FDA) approved GLOPERBA.
Top Players in the Global colchicine tablet Market:
Cipla Inc., Cardinal Health, Alchem International, Medinova AG, Odan Laboratories Ltd., Prasco Laboratories, Rhea Pharmaceutical, Takeda Pharmaceuticals, Romeg Therapeutics, LLC, Endo International plc, Mylan Pharmaceuticals Inc., West-Ward Pharmaceuticals, and Wockhardt, among others.
The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.
To know more about the report @ https://www.reportsanddata.com/report-detail/colchicine tablet-market
colchicine tablet Market Segmentation:
Dosage Formulation Outlook (Revenue, USD Million, 2019 - 2030)
- Solid
- Capsule
- Tablet
- Semisolid Gel
- Liquid
Application Outlook (Revenue, USD Million, 2019 - 2030)
- Actinic Keratosis
- Gout
- Behcet's Disease
- Dermatitis Herpetiformis
- Familial Mediterranean Fever
- Paget's Disease
- Other Applications
Route of Administration Outlook (Revenue, USD Million, 2019 - 2030)
- Oral
- Topical
Age Outlook (Revenue, USD Million, 2019 - 2030)
- Pediatric
- Adult
- Geriatric
Sales Channel Outlook (Revenue, USD Million, 2019 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End-User Outlook (Revenue, USD Million, 2019 - 2030)
- Hospitals Clinics
- Other End-Users
Global colchicine tablet Market Report: Regional Segmentation
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
Colchicine, the treatment of gout, can it help in the face of the Corona pandemic?Colchicine and its relationship to coronavirus.
Talking about the Coronavirus has become our primary concern lately, as everyone keeps searching for how to confront this global epidemic.
From here, the interest of all researchers in the world fell to search for any drug that might have helped reduce the Corona pandemic.In fact, colchicine is basically one of the most effective drugs for treating gout, but during my research on this drug, I found that some scientists praise its role in facing the Corona virus.So do colchicine tablets really play a role in combating covid 19 besides their role in treating gout, or are they just speculation !!!!
?This is what we will explain to you, dear reader, through this article
Erythema Nodosum Treatment in Delhi.
Treatments for erythema nodosum include anti-inflammatory drugs and corticosteroids by mouth or local injection.
Physicians sometimes administer colchicine to reduce inflammation.
Erythema nodosum (EN), also known as subacute migratory panniculitis of Vilanova and Piñol, is an inflammatory condition characterized by inflammation of the fat cells under the skin, resulting in tender red nodules or lumps that are usually seen on both shins.
Increasing prevalence of gout and other related disorders, rising public awareness, rise in R investment in various industries, and growing elderly population are key factors contributing to high CAGR of Colchicine Market during forecast period.Colchicine Market Size – USD 553.8 Million in 2018, Market Growth - CAGR of 9.3%, Market Trends – Wider application range of the drugThe newest report compiled by Reports and Data, titled ‘Global Colchicine Market Forecast to 2027,’ serves as an appropriate prototype of the global Colchicine market.
The report endows the reader with a panoramic view of the Colchicine industry, simultaneously offering viable insights into the anticipated market size, revenue share, and sales & distribution networks.
These insights are bound to help readers visualize the key outcomes of this industry in the near future and take necessary measures to stand tall, even during times as challenging as the current COVID-19 crisis.
Venture capitalists and the key businesses involved in this sector are the primary addressees of this report, which is intended to assist them in decision-making and formulating productive business plans.To Get a PDF Sample Copy of the Report, visit @ https://www.reportsanddata.com/sample-enquiry-form/2374In the later segment of this report, our team of market researchers has holistically covered the profound impact of the COVID-19 pandemic on the global Colchicine market.
The outbreak has resulted in several dramatic changes in the current Colchicine business sphere, wreaking a significant financial crunch for the leading vendors and producers in this industry.
The report concludes with vital data and information pertaining to the global market growth on both regional and global levels.Key participants include Abbott Laboratories, Hikma Pharmaceuticals, Cipla Limited, West Ward Pharmaceutical, Takeda Pharmaceuticals America, Inc., Cardinal Health, Major Pharmaceuticals, Excellium Pharmaceutical, Mylan Pharmaceuticals Inc., Odan LaboratoriesFor the purpose of this report, Reports and Data has segmented the colchicine market on the basis of dosage formulation, application, end use and region:Dosage Formulation Outlook (Revenue, USD Million; 2016-2026)TabletCapsuleSolutionCreamInjectionOthersApplication Outlook (Revenue, USD Million; 2016-2026)Acute GoutChronic GoutFamilial Mediterranean FeverGout ProphylaxisActinic KeratosisAmyloidosisBehcet's DiseasePericarditisPseudogoutDermatitis HerpetiformisPaget's DiseaseBiliary and Hepatic CirrhosisOthersEnd Use Outlook (Revenue, USD Million; 2016-2026)PediatricAdultGeriatricScope of the Global Colchicine Market:One of the significant components of the global Colchicine market is the methodical segmentation of the market.
Such tissues include the blood vessels, nerves, tendons, muscle, fat and lining of the joints.
Certain kinds of soft-tissue sarcoma are likely to be diagnosed in children while others are more likely to be diagnosed in adults.
The most common form of treatment for such a cancer type is surgical removal of the tumour.
Standard treatment options for standard soft-tissue sarcoma involve a single agent or combination systemic chemotherapy.
Targeted therapy treatment for soft-tissue sarcoma Targeted therapy involves the use of medications to identify and affect the cancer cells while also keeping the normal cell unharmed, by attacking the part of the cancer cells that distinguishes them from normal cells.
As doctors continue to observe the biology of sarcoma cells, targeted therapy using medications such as Pazopanib / Votrient is becoming a viable treatment for treating soft-tissue sarcoma.
Buy Tadarise 2.5mg Online relaxes muscles of the blood vessels and increases blood flow to particular areas of the body.
Tadalafil under the name of Cialis is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate).
Another brand of tadalafil is Adcircahttp://www.strapcart.com/product/buy-tadarise-2-5mg-online/
Buy Tadarise 2.5mg Online relaxes muscles of the blood vessels and increases blood flow to particular areas of the body.
tadarise reviewsunder the name of Cialis is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate).
Another brand of tadalafil is Adcirca
